Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Advertising & Marketing

Sales

Legal & Regulatory

Acquisition & Integration

Goodwill impairment

Restructuring costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Teladoc

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. Its portfolio of services and solutions covers medical subspecialties from non-urgent, episodic needs like flu and upper respiratory infections, to chronic, complicated medical conditions like cancer and congestive heart failure. The company was founded on June 13, 2002, by George Byron Brooks and Gary Wald and is headquartered in Purchase, NY.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Teladoc reports solid Q4 growth, eyes revenue optimization strategies

Teladoc's Q4 performance showed revenue growth and margin focus, with BetterHelp contributing significantly to profitability.
The company's strategic focus on virtual care expansion and revenue optimization positions Teladoc for continued success in the healthcare market.
While facing internal restructuring challenges, Teladoc's emphasis on growth drivers and operational efficiency presents opportunities for future growth and market leadership.

Teladoc Health excels in Q1, eyes growth and efficiency

Teladoc Health's Q1 performance was strong, with revenue exceeding expectations.
The company is focused on efficiency, innovation, and driving value in virtual care.
BetterHelp segment showed growth and stability, with improving margins expected.
Opportunities exist to capitalize on ad pricing stability and consumer behavior trends.

Teladoc surpasses revenue expectations, focuses on innovation and growth

Teladoc's Q2 performance exceeded expectations, with strong revenue growth and improved margins in both segments. The company's strategic focus on whole-person care, weight management, and AI enhancements positions it well for future growth. Challenges include managing drug costs and private company valuations, while opportunities lie in virtual care demand and strategic M&A.
Teladoc's financial strength, commitment to innovation, and focus on efficiency improvements are key strengths driving its performance. The company's ability to navigate challenges and capitalize on opportunities in the evolving healthcare landscape underscores its resilience and growth potential.

Teladoc Health surpasses Q3 expectations, eyes margin expansion in '24

Teladoc Health's Q3 performance exceeded expectations, driven by revenue growth and margin improvements.
The company is focused on enhancing cost efficiencies, profitability, and driving margin expansion.
Stable pricing environment and strong client demand present opportunities for future growth.
Operational review and strategic initiatives position Teladoc for continued success in the healthcare sector.

Teladoc reports robust 2023 earnings, eyes growth amid marketing challenges

Teladoc delivered strong financial performance in 2023 with notable growth in adjusted EBITDA and revenue. The company faces challenges in BetterHelp marketing yields and delayed consumer engagement efforts.
However, Teladoc's strategic strengths lie in its long-term outlook for revenue growth, margin expansion, and cost-saving initiatives. Opportunities exist in optimizing sales force structure and capital deployment for future growth.
Overall, Teladoc's focus on profitability, growth optimization, and strategic capital allocation positions it well for sustained success in the telehealth industry.

Teladoc Health reports solid Q1 performance amidst revenue challenges

Teladoc Health's Q1 2024 performance showcased revenue growth in Integrated Care but challenges in BetterHelp segment revenue and margin management.
The company's financial strength, product portfolio, and cost initiatives position it well for growth opportunities and strategic market positioning.
Addressing challenges in ad spend management and focusing on international market efficiency are key to unlocking growth potential and improving financial performance.
Overall, Teladoc's performance, strengths, challenges, and opportunities reflect a dynamic landscape with strategic focus on sustainable growth and operational efficiency.

Teladoc Health reports Q2 revenue dip, EBITDA growth; addresses challenges

Teladoc Health's Q2 2024 performance showed mixed results with revenue decline but EBITDA growth. The company is leveraging strengths in patient safety and technology while addressing challenges in customer acquisition costs. Opportunities lie in operational efficiency, insurance coverage access, and international expansion.

Teladoc Health reports Q3 revenue decline but strategic growth

Teladoc Health's Q3 2024 performance reflects mixed results with revenue decline but strategic growth in the Integrated Care segment.
The company's focus on customer-centric strategies, technology, and clinical excellence positions it well for future success and market leadership.
Challenges in revenue decline and expense management require Teladoc Health to balance short-term financial performance with long-term growth objectives.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002, by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in Purchase, NY.

Although this quarter was better than the last one, we're not out of the woods yet.

Why Teladoc Stock Crashed After Earnings

There was some good news in the midst of Teladoc's disappointing Q2 results.

Teladoc Stock: 3 Bright Spots Investors Are Ignoring

The remote healthcare provider posts a wider-than-expected quarterly loss after recording a $3 billion impairment charge.

Teladoc Stock Sinks on Wider Loss and Weak Guidance

CEDARHURST, N.Y. , July 27, 2022 /PRNewswire/ -- The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of Teladoc Health, Inc. (NYSE: TDOC), if they purchased the Company's securities between October 28, 2021 and April 27, 2022, inclusive (the "Class Period").

FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Teladoc Health, Inc. - TDOC

Teladoc Health, Inc. (NYSE:TDOC ) Q2 2022 Earnings Conference Call July 27, 2022 4:30 PM ET Company Participants Patrick Feeley - Vice President & Investor Relations Jason Gorevic - Chief Executive Officer Mala Murthy - Chief Financial Officer Conference Call Participants Ryan Daniels - William Blair Lisa Gill - JPMorgan Sandy Draper - Guggenheim Securities Richard Close - Canaccord Genuity Stephanie Davis - SVB Leerink Sean Dodge - RBC Charles Rhyee - Cowen Daniel Grosslight - Citi George Hill - Deutsche Bank Jessica Tassan - Piper Sandler A.J. Rice - Credit Suisse Stan Berenshteyn - Wells Fargo David Larsen - BTIG Operator Hello, and welcome to today's Teladoc Health Q2 Earnings Call.

Teladoc Health, Inc. (TDOC) CEO Jason Gorevic on Q2 2022 Results - Earnings Call Transcript

Teladoc Health Inc (NYSE: TDOC) shares are down 25% in extended trading after the telemedicine company reported wider-than-expected loss for its fiscal second quarter and lowered its full-year guidance. Key takeaways from Teladoc Q2 earnings report Lost $3.1 billion versus the year-ago figure of $133.8 million Per-share loss of $19.

Teladoc shares down 25% in extended trading: how come?

New York, New York--(Newsfile Corp. - July 27, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Teladoc Health, Inc. (NYSE: TDOC) between October 28, 2021 and April 27, 2022, both dates inclusive (the "Class Period"), of the important August 5, 2022 lead plaintiff deadline.

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Teladoc Health, Inc. Investors With Losses to Secure Counsel Before Important August 5 Deadline in Securities Class Action - TDOC

Shares of Teladoc Inc. plunged more than 11% in after-hours trading Thursday after the telehealth company took another multibillion-dollar impairment charge, helping to bring its total losses for the first six months of the year up to nearly $10 billion.

Teladoc loses $3 billion in three months, stock plummets

PURCHASE, NY, July 27, 2022 (GLOBE NEWSWIRE) --  Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, today reported financial results for the second quarter ended June 30, 2022.

Teladoc Health Reports Second-Quarter 2022 Results

Coinbase

Fate Therapeutics

MercadoLibre

Intellia Therapeutics

Tesla

Zoom Video

Cathie Wood stocks trading at a discount is our topic for today. The prominent fund manager and her team focus on disruptive innovation, considered by many to be a new paradigm in investing.

7 Cathie Wood Stocks Trading at a Discount Right Now

New York, New York--(Newsfile Corp. - July 25, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Teladoc Health, Inc. (NYSE: TDOC) between October 28, 2021 and April 27, 2022, both dates inclusive (the "Class Period"), of the important August 5, 2022 lead plaintiff deadline.

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Teladoc Health, Inc. Investors to Secure Counsel Before Important August 5 Deadline in Securities Class Action - TDOC

Teladoc Health's (TDOC) second-quarter results are likely to reflect growth in Subscription Access Fees.

Teladoc Health (TDOC) Gears Up for Q2 Earnings: What Lies Ahead?

PURCHASE, NY, July 25, 2022 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in whole-person virtual care, has named Mike Waters as chief operating officer. As COO, Waters will work closely with Jason Gorevic, CEO of Teladoc Health, on the organization's overall operations and execution and will take primary responsibility for ensuring Teladoc Health's member services and relations, supply chain, and provider network can effectively build and reliably deliver a distinctly seamless, integrated whole-person care experience. For more than two decades Mr. Waters has led strategic operations and growth initiatives for healthcare companies, helping to create accessible, affordable care services, as well as innovative ways to transform care experiences.

Teladoc Health Names Mike Waters as Chief Operating Officer

Pinterest

These remarkable businesses have the tools and intangibles necessary to quadruple your money by the turn of the decade.

3 Colossal Growth Stocks That Can Turn $250,000 Into $1 Million by 2030

AppHarvest

DraftKings

Rada Electronic

Riot Blockchain

TuSimple Holdings

These seven growth stocks are trading at a discount after the recent market correction and can provide big returns in the next 12-24 months. The post 7 Growth Stocks Trading at a Huge Discount Right Now appeared first on InvestorPlace.

7 Growth Stocks Trading at a Huge Discount Right Now

NEW YORK , July 22, 2022 /PRNewswire/ --  WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Teladoc Health, Inc. (NYSE: TDOC) between October 28, 2021 and April 27, 2022, both dates inclusive (the "Class Period"), of the important August 5, 2022 lead plaintiff deadline. SO WHAT: If you purchased Teladoc Health securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

ROSEN, A LEADING LAW FIRM, Encourages Teladoc Health, Inc. Investors with Losses to Secure Counsel Before Important August 5 Deadline in Securities Class Action - TDOC

NEW ORLEANS , July 22, 2022 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until August 5, 2022 to file lead plaintiff applications in a securities class action lawsuit against Teladoc Health, Inc. (NYSE: TDOC), if they purchased the Company's securities between October 28, 2021 and April 27, 2022, inclusive (the "Class Period").

TELADOC HEALTH SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Teladoc Health, Inc. - TDOC

Shopify

These stocks are both down more than 50% this year.

2 Beaten Down Stocks That Could Rally in the Second Half of 2022

Amazon expanding its presence in the telehealth market sent the stock crashing down.

Why Teladoc Stock Crashed on Thursday but Immediately Recovered

Teladoc (TDOC) stock is on the move today as investors in the company react to news of Amazon (AMZN) acquiring One Medical (ONEM). The post What Is Going on With Teladoc (TDOC) Stock Today?

What Is Going on With Teladoc (TDOC) Stock Today?

Amazon's big deal gives Teladoc shareholders a scare.

Why Teladoc Shares Are Falling Today

New York, New York--(Newsfile Corp. - July 21, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Teladoc Health, Inc. (NYSE: TDOC) between October 28, 2021 and April 27, 2022, both dates inclusive (the "Class Period"), of the important August 5, 2022 lead plaintiff deadline.SO WHAT: If you purchased Teladoc Health securities during the Class Period you may be entitled to compensation without payment of any...

TDOC FINAL DEADLINE: ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Teladoc Health, Inc. Investors With Losses Exceeding $100K to Secure Counsel Before Important August 5 Deadline in Securities Class Action - TDOC

Shares of Teladoc Health, Inc. (NYSE: TDOC) are trading lower today after Amazon.com, Inc. (NASDAQ: AMZN) announced the acquisition of One Medical (NASDAQ: ONEM) in an all cash deal, which has weighed on other telemedicine and digital health competitors.  What Happened?

Why Are Shares of Teladoc Health Down Today?

New York, New York--(Newsfile Corp. - July 19, 2022) - Pomerantz LLP announces that a class action lawsuit has been filed against Teladoc Health, Inc. ("Teladoc" or the "Company") (NYSE: TDOC) and certain of its officers. The class action, filed in the United States District Court for the Southern District of New York, and docketed under 22-cv-04687, is on behalf of a class consisting of all persons and entities other than Defendants that...

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Teladoc Health, Inc. of Class Action Lawsuit and Upcoming Deadline - TDOC

Doximity

Humana

The best telehealth stocks are undervalued after an abrupt sell-off. There are a few names such as TDOC, DOCS and HUM that stand out.

News for Teladoc Stock (TDOC)